RxDoctor Payments Data

Luciano Vargas, MD

Surgery · Omaha, NENPI 1720108384

Payments from drug & device makers

$2,578in general payments, 2019–2025

Across 22 payments — averaging $117.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$2K
  • Boston Scientific$140
  • Abbott$124
  • Davol Inc.$25
  • Medtronic$15
$924in research payments, 2019–2025

Across 2 payments — averaging $462.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Transmedics, Inc.$924

What the payments were for

  • Travel & lodging$1,98577%
  • Food & beverage$59223%

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical18$2,273
Boston Scientific1$140
Abbott1$124
Davol Inc.1$25
Medtronic1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,578 in reported general payments places this provider in the 65th percentile of 197 surgery providers in Nebraska.

See all surgery providers in Nebraska

Medicare billing

Part B allowed, 2024
$102,983
Medicare patients
159
Services billed
454

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase15$59,415

Paid to pharmacies, not to this prescriber.

Other surgery in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →